Key Takeaways
  • ALNY ($242.61): +6.1%, RVOL 0.8, between
  • FICO ($1161.59): +7.7%, RVOL 0.9, between
  • MELI ($1908.65): +7.3%, RVOL 1.6, at_supply
  • WAT ($415.84): +3.6%, RVOL 1.2, at_demand
  • OMDA ($24.47): +3.0%, RVOL 1.1, at_supply

Overview

Today’s scan produced 40 continuation breakout signals, a robust count that signals broad participation rather than an isolated squeeze. Under WaveRider’s Cautious regime classification, breadth sits at a healthy 57.6% above the SMA-40, but sentiment readings are conflicted (Very Bullish/Bearish), suggesting the market is digesting recent gains rather than trending cleanly. In this environment, selectivity matters more than volume of signals.

Leadership is concentrated in Health Care (3.2% ATR%) and Energy (3.3% ATR%), while Technology, Utilities, and Real Estate lag badly with negative ATR% readings. This is directly visible in our candidate list: seven of the top ten setups originate from Medical or Mining names, both of which carry above-average volatility expansion right now. Software’s lone representative, FICO, sits in a lagging sector and is treated with caution despite a strong headline move.

Today’s Quality Score: 3.5/5. The signal count and institutional depth (several names carrying 1,000+ funds) support conviction, but the Cautious regime caps enthusiasm — only setups with clean zone structure and sector tailwinds earn top marks. Sector concentration is moderate: Medical dominates numerically, but Mining and Retail provide diversification, and the presence of multiple at_demand setups gives traders defined risk rather than chasing extended moves.

Top 5 Picks

WAT ($415.84) — Medical / Medical-Systems

Waters Corp posts the cleanest technical picture on the list: price is sitting directly at_demand (404.25–406.80, 1h timeframe) with an ATR%-M of 3.3, the highest volatility expansion reading among today’s candidates and a direct match to the leading Health Care sector. RVOL of 1.2 confirms real participation behind the 3.6% move, and the stock is just 1.1% off its 52-week high, indicating trend continuation rather than a bounce.

Level Price
Entry $415.84
Stop $402.00 (below demand zone)
Target $443.50 (2:1 R/R)

Institutional Backing: 2,503 funds (INST classification), Bucket B1 — deep institutional sponsorship supports the breakout thesis.

MELI ($1908.65) — Retail / Retail-Internet

MercadoLibre is pressing into supply (1936.52–1944.99, 30m) on RVOL of 1.6 and a 7.3% gain, with ATR%-M at 2.0 confirming volatility expansion. A confirmed close above the supply ceiling would signal absorption of overhead resistance and open room toward new highs, especially given the stock remains 25.1% below its 52-week high with plenty of upside runway.

Level Price
Entry $1,945.00 (breakout above supply)
Stop $1,818.00 (below demand zone)
Target $2,050.00

Institutional Backing: 3,386 funds (INST classification), Bucket B1 — the largest institutional footprint in today’s dataset.

PAAS ($50.30) — Mining / Mining-Gold/Silver/Gems

Pan American Silver breaks out on RVOL 1.4 with a 7.9% gain and ATR%-M of 2.1, positioned comfortably between a distant monthly demand zone (33.08–45.67) and daily supply (53.05–54.33) just 5.47% overhead. The wide berth from support gives this setup favorable structure, and precious metals continue attracting flow as a Cautious-regime hedge.

Level Price
Entry $50.30
Stop $46.98 (2x ADR below entry)
Target $54.30 (supply zone)

Institutional Backing: 1,412 funds (INST classification), Bucket B2.

TEM ($61.25) — Medical / Medical-Research

Tempus AI is the momentum standout of the session — a 24.1% surge on RVOL of 4.8, the highest reading in today’s scan by a wide margin. ATR%-M of 2.9 confirms genuine volatility expansion, and the stock sits between a wide monthly demand base and weekly supply at 65.32–69.41. This is an aggressive, high-reward continuation play best sized conservatively given the outsized single-day move.

Level Price
Entry $61.25
Stop $57.00 (below demand upper bound)
Target $65.30, then $69.40

Institutional Backing: 422 funds (non-INST), Bucket B2 — smaller-cap sponsorship, size accordingly.

ASND ($259.62) — Medical / Medical-Profitable Biotech

Ascendis Pharma is testing supply (261.06–267.35, 4h) just 0.55% overhead on a 4.3% gain and RVOL of 1.0. ATR%-M of 1.1 is modest but positive, and the setup benefits from Health Care sector leadership. A clean break above the tight supply band would confirm continuation with the stock still 8.0% below its 52-week high.

Level Price
Entry $267.50 (breakout above supply)
Stop $243.00 (below demand zone)
Target $285.00

Institutional Backing: 584 funds (non-INST), Bucket B1,B2.

Honorable Mentions

  • ALNY — Strong 2,275-fund institutional base, but low RVOL (0.8) and negative ATR%-M temper conviction today.
  • FICO — Big 7.7% move, but Technology-adjacent Software sector is lagging in this regime; watch rather than chase.
  • OMDA — At_supply with strong zone strength (8.8), but thin institutional coverage (163 funds) adds risk.
  • UUUU — Clean at_demand setup in Mining, but light institutional backing (447 funds) limits size conviction.
  • ASM — Highest ATR%-M (3.9) of the group, but only 146 funds of institutional support and a between-zone entry.

Strategy Summary

Today’s continuation setups skew toward Medical and Mining names, both benefiting from sector-level volatility expansion, while lagging Technology/Software signals should be treated with reduced size or avoided outright. The best risk/reward sits in WAT and PAAS, where price is well-positioned relative to demand zones with clear stop placement. MELI and ASND offer institutional-grade continuation plays right at resistance — wait for confirmed breaks before entry. TEM is the highest-octane opportunity but requires disciplined position sizing given its extended move. Overall, this is a moderately aggressive day for selective continuation trades, with institutional depth and zone structure serving as the key differentiators between winners and false breakouts.

Share: